Submit Feedback
Ticker
CAH
MCK
Headquarter
Dublin ,OH
US
Irving ,TX
US
CEO
Mr. Jason M. Hollar
Mr. Brian S. Tyler Ph.D.
Industry
Medical - Distribution
Medical - Distribution
Stock Price
Stock Price
Market Cap
$28.87B
$73.30B
Employees
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Employees
  • 46.50K
  • 48.00K
  • 48.90K
  • 75.00K
  • 51.00K
  • 51.00K
Y/Y
1.69%
3.23%
1.88%
1.32%
32%
0%

Income Statement

Revenue
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Revenue
  • $181.36B
  • $205.01B
  • $226.83B
  • $263.97B
  • $276.71B
  • $308.95B
Y/Y
11.63%
13.04%
10.64%
10.8%
4.83%
11.65%
Revenue by Products / Services
Revenue by Geography
Research and Development
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Research and Development
  • -
  • -
  • -
  • $70.00M
  • $89.00M
  • $179.00M
Y/Y
0%
0%
0%
5.41%
27.14%
101.12%
Operating Income
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Operating Income
  • $1.65B
  • $727.00M
  • $1.24B
  • $2.85B
  • $4.38B
  • $3.91B
Y/Y
10.48%
55.89%
70.98%
19.02%
53.61%
10.77%
Tax Rate (%)
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Tax Rate (%)
  • -21.00%
  • 59.00%
  • 29.00%
  • 33.00%
  • 20.00%
  • 17.00%
Y/Y
76.3%
377.97%
50.82%
138.88%
40.74%
15.09%
Net Income
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Net Income
  • -$932.00M
  • $261.00M
  • $852.00M
  • $1.11B
  • $3.56B
  • $3.00B
Y/Y
252.54%
128%
226.44%
125.67%
219.57%
15.67%

Assets & Liabilities | Cash Flow

Total Assets
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Total Assets
  • $43.88B
  • $43.42B
  • $45.12B
  • $63.30B
  • $62.32B
  • $67.44B
Y/Y
1.29%
1.05%
3.92%
2.64%
1.55%
8.22%
Total Liabilities
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Total Liabilities
  • $44.58B
  • $46.27B
  • $48.33B
  • $65.09B
  • $63.81B
  • $69.04B
Y/Y
4.51%
3.78%
4.46%
2.39%
1.97%
8.2%
Capital Expenditures (Capex)
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Capital Expenditures (Capex)
  • -$387.00M
  • -$481.00M
  • -$511.00M
  • -$535.00M
  • -$558.00M
  • -$687.00M
Y/Y
3.25%
24.29%
6.24%
16.54%
4.3%
23.12%

Profitability

Operating Income Margin (%)
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Operating Income Margin (%)
  • 0.91%
  • 0.35%
  • 0.55%
  • 1.08%
  • 1.58%
  • 1.27%
Y/Y
19.47%
61.54%
57.14%
27.03%
46.3%
19.62%
Net Income Margin (%)
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Net Income Margin (%)
  • -0.51%
  • 0.13%
  • 0.38%
  • 0.42%
  • 1.29%
  • 0.97%
Y/Y
234.21%
125.49%
192.31%
123.08%
207.14%
24.81%
EBITDA
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
EBITDA
  • $126.00M
  • $1.44B
  • $1.98B
  • $3.11B
  • $5.74B
  • $4.67B
Y/Y
90.38%
1043.65%
37.27%
186.4%
84.58%
18.62%
Free Cash Flow (FCF)
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Free Cash Flow (FCF)
  • $2.74B
  • $2.36B
  • $3.25B
  • $3.90B
  • $4.60B
  • $3.63B
Y/Y
34.8%
13.78%
37.87%
0.05%
18%
21.17%

Ratios

Return on Equity (ROE)
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Return on Equity (ROE)
  • 132.01%
  • -9.15%
  • -26.52%
  • -49.03%
  • -191.71%
  • -152.31%
Y/Y
287.58%
106.93%
189.84%
100.24%
291.01%
20.55%
Return on Assets (ROA)
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Return on Assets (ROA)
  • -2.12%
  • 0.60%
  • 1.89%
  • 1.76%
  • 5.71%
  • 4.45%
Y/Y
254.74%
128.3%
215%
126.39%
224.43%
22.07%
Debt to Equity
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Debt to Equity
  • -752.83%
  • -164.89%
  • -158.48%
  • -263.69%
  • -308.02%
  • -292.29%
Y/Y
316.58%
78.1%
3.89%
99.24%
16.81%
5.11%

Valuation

Enterprise Value
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Enterprise value
  • $15.18B
  • $25.34B
  • $23.91B
  • $50.63B
  • $52.86B
  • $74.27B
Y/Y
22.14%
66.92%
5.65%
46.98%
4.39%
40.51%
Enterprise value to Revenue
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Enterprise value to Revenue
  • 0.08
  • 0.12
  • 0.11
  • 0.19
  • 0.19
  • 0.24
Y/Y
30.25%
47.67%
14.72%
32.64%
0.42%
25.86%
Enterprise value to EBITDA
Years
  • 2022
  • 2023
  • 2024
  • 2022
  • 2023
  • 2024
Enterprise value to EBITDA
  • 120.49
  • 17.59
  • 12.09
  • 16.30
  • 9.22
  • 15.91
Y/Y
709.46%
85.4%
31.26%
270.11%
43.45%
72.66%